首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer management and research

缩写:CANCER MANAG RES

ISSN:1179-1322

e-ISSN:1179-1322

IF/分区:2.6/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引5132
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yu-Jen Chiu,Chiao-Yun Cheng,Kuan-Cheng Chen et al. Yu-Jen Chiu et al.
Background: Melanoma in Asian populations exhibits distinct clinicopathological features compared to Western populations. While acral melanoma (AM) is the predominant subtype among Asians, recent studies have demonstrated...
Darshit Dave,Bridget S Angucia,Caroline Komukama et al. Darshit Dave et al.
Background: Cancer cachexia is a debilitating syndrome contributing to significant morbidity and mortality. Despite its impact on survival and quality of life, it remains under-recognized and undertreated, particularly in...
Chunyan Wu,Yujia Li,Xianglian Wang et al. Chunyan Wu et al.
Objective: To construct a nomogram model for individualized prediction of risk of deep vein thrombosis (DVT) in renal cell carcinoma (RCC) patients after laparoscopic partial nephrectomy (PN). ...
Yongan Fu,Zongda Cai,Yangqiang Wang et al. Yongan Fu et al.
Introduction: Bone marrow-derived mesenchymal stem cells (BMSCs) are recruited into the gastric cancer (GC) microenvironment and promote progression, though the underlying mechanisms remain unclear. This study investigate...
Michał Złoch,Ewelina Sibińska,Fernanda Monedeiro et al. Michał Złoch et al.
Purpose: The urinary microbiome may influence the development of radiation-induced complications in prostate cancer. However, its dynamics during and after radiotherapy (RT) remain unclear. This study aimed to use matrix-...
Shina Qiao,Xiaoming Zhang,Suming Tian et al. Shina Qiao et al.
Patients undergoing treatment with immune checkpoint inhibitors (ICIs) for advanced lung cancer are at increased risk of viral reactivation and severe neuropathic pain. These complications exacerbate the overall symptom burden and psycholog...
Haixing Wei,Jie Wang,Qing Wu et al. Haixing Wei et al.
Cholangiocarcinoma (CCA) is a rare but aggressive malignancy with a rising global incidence and few therapeutic options for advanced disease. In recent decades, precision oncology for CCA has advanced rapidly, particularly through the devel...
Young Saing Kim,Eung Chang Lee,Hee Young Lee Young Saing Kim
Purpose: Small cell lung cancer (SCLC) is an aggressive malignancy with poor survival. Existing prognostic models provide limited patient-level risk stratification and often overlook accessible clinical and imaging data. ...
Jingyi Yang,Zineng Yuan,Shasha Mei et al. Jingyi Yang et al.
Oral squamous cell carcinoma (OSCC) is the most common malignant tumor of the oral cavity, accounting for the majority of oral cancers, and early detection is crucial for improving patient survival rates and prognosis. Traditional diagnosti...
Zain Z Zakaria,Yasmin Mohammed Ameen Ahen,Nawar Haj Ahmed et al. Zain Z Zakaria et al.
Background: Cancer is the second leading cause of death worldwide, accounting for approximately 8.97 million deaths, and is projected to surpass ischemic heart disease as the leading cause by 2060. Lung, liver, and stomac...